Stage IIB Skin Melanoma Completed Phase 0 Trials for Melanoma antigen recognized by T-cells 1 (DB15081)

Also known as: Stage IIB Cutaneous Melanoma

IndicationStatusPhase
DBCOND0054560 (Stage IIB Skin Melanoma)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02320305MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by SurgeryTreatment